Bleakley Financial Group LLC increased its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 15.5% during the fourth quarter, Holdings Channel.com reports. The fund owned 1,587 shares of the biotechnology company’s stock after buying an additional 213 shares during the period. Bleakley Financial Group LLC’s holdings in Axon Enterprise were worth $410,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently modified their holdings of AXON. Capital International Investors grew its position in shares of Axon Enterprise by 605.2% during the 1st quarter. Capital International Investors now owns 2,660,634 shares of the biotechnology company’s stock valued at $366,449,000 after acquiring an additional 2,283,343 shares during the period. Sands Capital Management LLC grew its position in shares of Axon Enterprise by 101.6% during the 2nd quarter. Sands Capital Management LLC now owns 1,993,126 shares of the biotechnology company’s stock valued at $388,899,000 after acquiring an additional 1,004,556 shares during the period. BlackRock Inc. grew its position in shares of Axon Enterprise by 11.7% during the 1st quarter. BlackRock Inc. now owns 8,329,479 shares of the biotechnology company’s stock valued at $1,872,883,000 after acquiring an additional 870,481 shares during the period. Norges Bank acquired a new stake in Axon Enterprise in the 4th quarter worth about $102,920,000. Finally, Westfield Capital Management Co. LP boosted its holdings in Axon Enterprise by 184.3% in the 3rd quarter. Westfield Capital Management Co. LP now owns 696,193 shares of the biotechnology company’s stock worth $138,535,000 after buying an additional 451,350 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
AXON has been the topic of several research analyst reports. TheStreet cut Axon Enterprise from a “b” rating to a “c+” rating in a report on Tuesday, February 27th. Morgan Stanley lifted their price objective on Axon Enterprise from $250.00 to $285.00 and gave the stock an “equal weight” rating in a report on Wednesday, February 28th. Robert W. Baird lifted their price objective on Axon Enterprise from $260.00 to $300.00 and gave the stock an “outperform” rating in a report on Thursday, February 22nd. Needham & Company LLC lifted their price objective on Axon Enterprise from $315.00 to $400.00 and gave the stock a “buy” rating in a report on Wednesday, April 10th. Finally, JPMorgan Chase & Co. lifted their price objective on Axon Enterprise from $330.00 to $365.00 and gave the stock an “overweight” rating in a report on Thursday. Two investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat.com, Axon Enterprise currently has a consensus rating of “Moderate Buy” and an average target price of $312.64.
Read Our Latest Stock Report on AXON
Axon Enterprise Stock Down 4.1 %
AXON stock opened at $310.81 on Monday. The firm has a market cap of $23.45 billion, a PE ratio of 135.14 and a beta of 0.93. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.66 and a current ratio of 3.00. The firm’s 50 day moving average price is $297.42 and its 200-day moving average price is $255.25. Axon Enterprise, Inc. has a one year low of $175.37 and a one year high of $329.87.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last released its quarterly earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 EPS for the quarter, beating the consensus estimate of $0.48 by $0.29. The firm had revenue of $432.14 million for the quarter, compared to analyst estimates of $418.97 million. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. On average, equities research analysts anticipate that Axon Enterprise, Inc. will post 2.43 EPS for the current year.
Axon Enterprise Company Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Stories
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Axon Enterprise and related companies with MarketBeat.com’s FREE daily email newsletter.
